Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.900 | 1.000 | 17 | 2007 | 2018 | |||||
Non-alcoholic Fatty Liver Disease
|
222 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.790 | 1.000 | 10 | 2011 | 2019 | |||||
Triglycerides measurement
|
1418 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 10 | 2007 | 2019 | |||||
Fasting blood glucose measurement
|
212 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 7 | 2010 | 2019 | |||||
Metabolic Syndrome X
|
591 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.830 | 1.000 | 6 | 2010 | 2018 | |||||
Diabetes
|
710 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.740 | 1.000 | 5 | 2010 | 2016 | |||||
Diabetes Mellitus
|
824 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.740 | 1.000 | 5 | 2010 | 2016 | |||||
Arthritis, Gouty
|
2356 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 4 | 2010 | 2017 | |||||
Gestational Diabetes
|
224 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.040 | 1.000 | 4 | 2017 | 2018 | |||||
Gout
|
2354 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 4 | 2010 | 2017 | |||||
Hypertriglyceridemia
|
169 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.730 | 1.000 | 4 | 2010 | 2017 | |||||
Serum total cholesterol measurement
|
1243 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 4 | 2012 | 2019 | |||||
Body mass index
|
2689 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 3 | 2012 | 2019 | |||||
C-reactive protein measurement
|
624 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 3 | 2008 | 2019 | |||||
Coronary heart disease
|
1178 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.810 | 1.000 | 3 | 2010 | 2016 | |||||
Dyslipidemias
|
184 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.030 | 1.000 | 3 | 2008 | 2018 | |||||
elevated blood glucose level
|
111 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 3 | 2011 | 2018 | |||||
Glucose measurement
|
111 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 3 | 2011 | 2018 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 3 | 2008 | 2019 | |||||
Obesity
|
1111 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.030 | 1.000 | 3 | 2009 | 2018 | |||||
Steatohepatitis
|
75 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.030 | 1.000 | 3 | 2013 | 2018 | |||||
Cerebrovascular accident
|
591 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.710 | 1.000 | 2 | 2010 | 2016 | |||||
Crohn Disease
|
1147 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 2 | 2008 | 2015 | |||||
Fatty Liver
|
35 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||
Uric acid measurement (procedure)
|
1463 | 0.658 | 0.400 | 2 | 27518370 | intron variant | T/C | snv | 0.67 | 0.800 | 1.000 | 2 | 2009 | 2015 |